Humana stock surged approximately 14% in Friday's premarket trading after newly released Medicare Advantage quality ratings showed a dramatic improvement for the insurer, while rival CVS Heal
Humana stock surged approximately 14% in Friday's premarket trading after newly released Medicare Advantage quality ratings showed a dramatic improvement for the insurer, while rival CVS Health faced weaker results for its Aetna business.
The rally followed confirmation that 95% of Humana's Medicare Advantage members are enrolled in plans rated four stars or higher for 2027, compared with roughly 20% under the previous year's ratings.
According to the official CMS ratings, the changes will influence insurers' quality bonus payments in 2028.
The turnaround could represent a substantial financial benefit for Humana, with analysts estimating approximately $3.6 billion in potential additional revenue.
Humana's Medicare Upgrade Reverses Earlier LossesHumana's largest Medicare Advantage contract, H5216, improved from 3.5 to four stars, potentially restoring its eligibility for government quality bonuses.
The contract covers approximately 2.4 million members, making the improvement particularly significant.
Humana also announced that 42% of its Medicare Advantage members are now enrolled in plans rated at least 4.5 stars.
The improvement follows years of rating-related financial pressure that previously weakened profitability and forced insurers to reconsider their coverage strategies.
Recent Medicare Advantage changes have already prompted Humana, CVS and UnitedHealth to reduce their geographic footprints or adjust plan availability.
<iframe src=”https://widgets.coincodex.com/w/66732af0-00a1-42be-87dc-2b0f9cb888a9?site=coinpaper&mode=light” width=”100%” height=”420” frameborder=”0” referrerpolicy=”no-referrer-when-downgrade” style=”border:0;background:transparent;border-radius:0px;”></iframe>CVS and UnitedHealth Face Ratings PressureHumana's improvement contrasts with a more difficult outcome for competitors.
CVS Health's Aetna said more than 69% of its Medicare Advantage members will be enrolled in four-star or higher plans in 2027, down from more than 81% for 2026.
Although Aetna emphasized its clinical performance in an official statement, the decline creates concerns over future quality bonuses.
CVS shares slipped approximately 2%, while UnitedHealth also experienced pressure following its ratings results.
The divergence is notable because the industry recently benefited from a Medicare payment increase that initially lifted major health insurance stocks.
